Genetic variants in anti-Müllerian hormone-related genes and breast cancer risk: results from the AMBER consortium | Zendy

Hazel B. Nichols | Zendy; Mariaelisa Graff | Zendy; Jeannette T. Bensen | Zendy; Kathryn L. Lunetta | Zendy; Katie M. O’Brien | Zendy; Melissa A. Troester | Zendy; Lindsay A. Williams | Zendy; Kristin L. Young | Zendy; Chi-Chen Hong | Zendy; Song Yao | Zendy; Christopher A. Haiman | Zendy; Edward A. RuizNarváez | Zendy; Christine B. Ambrosone | Zendy; Julie R. Palmer | Zendy; Andrew F. Olshan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Genetic variants in anti-Müllerian hormone-related genes and breast cancer risk: results from the AMBER consortium

Author(s) -

Hazel B. Nichols,

Mariaelisa Graff,

Jeannette T. Bensen,

Kathryn L. Lunetta,

Katie M. O’Brien,

Melissa A. Troester,

Lindsay A. Williams,

Kristin L. Young,

Chi-Chen Hong,

Song Yao,

Christopher A. Haiman,

Edward A. RuizNarváez,

Christine B. Ambrosone,

Julie R. Palmer,

Andrew F. Olshan

Publication year - 2020

Publication title -

breast cancer research and treatment

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.908

H-Index - 154

eISSN - 1573-7217

pISSN - 0167-6806

DOI - 10.1007/s10549-020-05944-4

Subject(s) - breast cancer , medicine , anti müllerian hormone , oncology , odds ratio , single nucleotide polymorphism , menopause , cancer , gynecology , breast disease , logistic regression , confidence interval , genotype , hormone , biology , gene , genetics

Circulating anti-Müllerian hormone (AMH) levels are positively associated with time to menopause and breast cancer risk. We examined breast cancer associations with single nucleotide polymorphisms (SNPs) in the AMH gene or its receptor genes, ACVR1 and AMHR2, among African American women.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research